8 Dec 2023 | Misc, Radiopharmaceutical Therapy
GlobalData Reports that Venture Capital Deals in radiopharmaceutical companies have grown 550% to $408m in 2023 GlobalData reports that venture capital deals in radiopharmaceuticals have grown by 550% this year totalling $408m. It was only back in 2017 when the level...
12 Sep 2023 | [Ga-68]EMP-100, Collaborations, Radiopharmaceutical Therapy
Dr Lena Unterrainer presented [Ga-68]EMP-100 as one of the “dark horses of theranostics” and showed the data of [Ga-68]EMP-100 in...
1 Mar 2023 | [Ga-68]EMP-100, Collaborations
A case of a 56-year-old female former smoker with stage IV EGFR mutation-positive NSCLC (lymphogenic, pulmonary, hepatic, and cerebral metastases is presented. Stage: cT3, cN3, cM1b) and concomitant MET exon 14 skipping mutation. After multiple pretreatments including...
1 Mar 2023 | Corporate, Events
Edinburgh Molecular Imaging appoints Dr Rob James as Non-Executive Chairman Rob is currently the Managing Partner of Sixth Element Capital and has over 20 years of experience of working in early-stage companies developing oncology drugs. He first worked at Cancer...
11 Apr 2022 | Collaborations, EMI-137
Patients undergoing prophylactic central compartment dissection (PCLND) for papillary thyroid cancer (PTC) are often overtreated. This study aimed to determine if molecular fluorescence-guided imaging (MFGI) and spectroscopy can be useful for detecting PTC nodal...
6 Dec 2021 | [Ga-68]EMP-100, Collaborations
This first in‑human biodistribution and imaging study for 68Ga‑EMP‑100 in metastatic renal cell carcinoma independently carried out by LMU Munich, Germany, evaluated uptake characteristics in metastases and primary RCC. Conclusion: Visualization of c-MET expression...
21 May 2021 | Collaborations, EMI-137
This pilot study suggest that c-MET is a promising target for fluorescence-guided tumour identification, with the potential to improve margin assessment in pSCC. The c-MET targeted approach proved to be compatible with lymphatic mapping performed in the same patient...